• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体介导的肺炎克雷伯菌荚膜改变。

Complement mediated Klebsiella pneumoniae capsule changes.

机构信息

Department of Health Science and Technology, Aalborg University, Fredrik Bajers Vej 3b, 9220, Aalborg, Denmark.

Department of Biomedicine, Aarhus University, Wilhelms Meyers Alle 4, 8000, Aarhus, Denmark.

出版信息

Microbes Infect. 2020 Jan-Feb;22(1):19-30. doi: 10.1016/j.micinf.2019.08.003. Epub 2019 Aug 29.

DOI:10.1016/j.micinf.2019.08.003
PMID:31473336
Abstract

The Gram-negative bacterium Klebsiella pneumoniae is an opportunistic pathogen, which can cause life-threatening infections such as sepsis. Worldwide, emerging multidrug resistant K. pneumoniae infections are challenging to treat, hence leading to increased mortality. Therefore, understanding the interactions between K. pneumoniae and the immune system is important to develop new treatment options. We characterized ten clinical K. pneumoniae isolates obtained from blood of bacteremia patients. The interaction of the isolates with human serum was investigated to elucidate how K. pneumoniae escapes the host immune system, and how complement activation by K. pneumoniae changed the capsule structure. All K. pneumoniae isolates activated the alternative complement pathway despite serum resistance of seven isolates. One serum sensitive isolate activated two or all three pathways, and this isolate was lysed and had numerous membrane attack complexes in the outer membrane. However, we also found deposition of complement components in the capsule of serum resistant isolates resulting in morphological capsule changes and capsule shedding. These bacteria did not lyse, and no membrane attack complex was observed despite deposition of C5b-9 within the capsule, indicating that the capsule of serum resistant K. pneumoniae isolates is a defense mechanism against complement-mediated lysis.

摘要

革兰氏阴性菌肺炎克雷伯菌是一种机会致病菌,可引起危及生命的感染,如败血症。在全球范围内,新出现的多药耐药肺炎克雷伯菌感染难以治疗,因此导致死亡率增加。因此,了解肺炎克雷伯菌与免疫系统之间的相互作用对于开发新的治疗方法很重要。我们对从菌血症患者血液中获得的 10 株临床肺炎克雷伯菌分离株进行了表征。研究了分离株与人血清的相互作用,以阐明肺炎克雷伯菌如何逃避宿主免疫系统,以及肺炎克雷伯菌激活补体如何改变荚膜结构。尽管有 7 株分离株对血清有抗性,但所有肺炎克雷伯菌分离株都激活了替代补体途径。一个血清敏感的分离株激活了两个或所有三个途径,并且这个分离株被裂解并且在外膜中有许多膜攻击复合物。然而,我们还发现补体成分在血清抗性分离株的荚膜中沉积,导致形态荚膜改变和荚膜脱落。这些细菌没有裂解,并且尽管在荚膜内沉积了 C5b-9,但没有观察到膜攻击复合物,表明血清抗性肺炎克雷伯菌分离株的荚膜是对补体介导的裂解的防御机制。

相似文献

1
Complement mediated Klebsiella pneumoniae capsule changes.补体介导的肺炎克雷伯菌荚膜改变。
Microbes Infect. 2020 Jan-Feb;22(1):19-30. doi: 10.1016/j.micinf.2019.08.003. Epub 2019 Aug 29.
2
Complement Susceptibility in Relation to Genome Sequence of Recent Klebsiella pneumoniae Isolates from Thai Hospitals.近期泰国医院分离的肺炎克雷伯菌与全基因组序列相关的补体易感性。
mSphere. 2018 Nov 7;3(6):e00537-18. doi: 10.1128/mSphere.00537-18.
3
In Vivo Evolution of a Klebsiella pneumoniae Capsule Defect With wcaJ Mutation Promotes Complement-Mediated Opsonophagocytosis During Recurrent Infection.在复发性感染过程中,携带 wcaJ 突变的肺炎克雷伯菌荚膜缺陷的体内进化促进补体介导的调理吞噬作用。
J Infect Dis. 2024 Jul 25;230(1):209-220. doi: 10.1093/infdis/jiae003.
4
Complement resistance mechanisms of Klebsiella pneumoniae.肺炎克雷伯菌的补体抗性机制
Immunobiology. 2016 Oct;221(10):1102-9. doi: 10.1016/j.imbio.2016.06.014. Epub 2016 Jun 16.
5
Genomic Profiling Reveals Distinct Routes To Complement Resistance in Klebsiella pneumoniae.基因组分析揭示了肺炎克雷伯菌中补体耐药的不同途径。
Infect Immun. 2020 Jul 21;88(8). doi: 10.1128/IAI.00043-20.
6
Survival of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 258 in Human Blood.耐碳青霉烯类肺炎克雷伯菌序列型258在人血液中的存活情况。
Antimicrob Agents Chemother. 2017 Mar 24;61(4). doi: 10.1128/AAC.02533-16. Print 2017 Apr.
7
Complement killing of clinical Klebsiella pneumoniae isolates is serum concentration dependent.补体对临床分离的肺炎克雷伯菌的杀伤作用呈血清浓度依赖性。
Microbes Infect. 2023 May;25(4):105074. doi: 10.1016/j.micinf.2022.105074. Epub 2022 Nov 3.
8
Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing.肺炎克雷伯菌对补体介导杀伤的耐药机制。
Infect Immun. 1992 Jun;60(6):2529-35. doi: 10.1128/iai.60.6.2529-2535.1992.
9
Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates.荚膜多糖是脂多糖O侧链缺陷型肺炎克雷伯菌临床分离株中的主要补体抗性因子。
Infect Immun. 2000 Feb;68(2):953-5. doi: 10.1128/IAI.68.2.953-955.2000.
10
Klebsiella LPS O1-antigen prevents complement-mediated killing by inhibiting C9 polymerization.肺炎克雷伯菌脂多糖 O1 抗原通过抑制 C9 聚合来防止补体介导的杀伤。
Sci Rep. 2024 Sep 5;14(1):20701. doi: 10.1038/s41598-024-71487-z.

引用本文的文献

1
Urinary Multidrug-Resistant : Essential Oil Countermeasures in a One Health Case Report.泌尿道多重耐药:“同一健康”案例报告中的精油应对措施
Microorganisms. 2025 Aug 1;13(8):1807. doi: 10.3390/microorganisms13081807.
2
The role of opsonophagocytosis in killing of in human blood.调理吞噬作用在人体血液中杀灭(此处原文不完整,推测可能是某种病原体之类的词)的作用。
Curr Res Microb Sci. 2025 Jul 24;9:100449. doi: 10.1016/j.crmicr.2025.100449. eCollection 2025.
3
Weberviruses are gut-associated phages that infect Klebsiella spp.韦氏病毒是与肠道相关的噬菌体,可感染克雷伯氏菌属。
FEMS Microbiol Ecol. 2025 Apr 14;101(5). doi: 10.1093/femsec/fiaf043.
4
Capsular Polysaccharide as a Potential Target in Hypervirulent and Drug-Resistant Treatment.荚膜多糖作为高毒力和耐药性治疗的潜在靶点
Infect Drug Resist. 2025 Mar 3;18:1253-1262. doi: 10.2147/IDR.S493635. eCollection 2025.
5
Characterization and functionality of 1003 isolated from chicken cecum against .从鸡盲肠分离出的1003对……的特性及功能
Front Cell Infect Microbiol. 2024 Dec 13;14:1432422. doi: 10.3389/fcimb.2024.1432422. eCollection 2024.
6
Bacteriophage treatment is effective against carbapenem-resistant (KPC) in a neutropenic murine model of gastrointestinal translocation and renal infection.在中性粒细胞减少的胃肠道易位和肾脏感染小鼠模型中,噬菌体治疗对耐碳青霉烯类(KPC)有效。
Antimicrob Agents Chemother. 2025 Feb 13;69(2):e0091924. doi: 10.1128/aac.00919-24. Epub 2024 Dec 20.
7
Host heterogeneity in humoral bactericidal activity can be complement independent.体液杀菌活性的宿主异质性可以不依赖补体。
Front Immunol. 2024 Sep 18;15:1457174. doi: 10.3389/fimmu.2024.1457174. eCollection 2024.
8
Agnostic B cell selection approach identifies antibodies against K. pneumoniae that synergistically drive complement activation.不可知B细胞选择方法鉴定出可协同驱动补体激活的抗肺炎克雷伯菌抗体。
Nat Commun. 2024 Sep 16;15(1):8100. doi: 10.1038/s41467-024-52372-9.
9
In Vivo Evolution of a Klebsiella pneumoniae Capsule Defect With wcaJ Mutation Promotes Complement-Mediated Opsonophagocytosis During Recurrent Infection.在复发性感染过程中,携带 wcaJ 突变的肺炎克雷伯菌荚膜缺陷的体内进化促进补体介导的调理吞噬作用。
J Infect Dis. 2024 Jul 25;230(1):209-220. doi: 10.1093/infdis/jiae003.
10
Antibiotic resistance and its correlation with biofilm formation and virulence genes in Klebsiella pneumoniae isolated from wounds.从伤口中分离出的肺炎克雷伯菌的抗生素耐药性及其与生物膜形成和毒力基因的相关性。
J Appl Genet. 2024 Dec;65(4):925-935. doi: 10.1007/s13353-024-00893-w. Epub 2024 Jul 20.